Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Herzuma (trastuzumab biosimilar) for the Treatment of Breast and Gastric Cancers

Drug Name

Herzuma® / trastuzumab biosimilar / CT-P6

Developed by

Celltrion and Teva Pharmaceutical Industries

Therapy Class

Monoclonal antibody (mAb) biosimilar

Current Indications

Breast and gastric cancers

Market Sector


Development Status

Approved in South Korea, and Europe

Go Top